Medication-induced hyperlipoproteinemia

Medication-induced hyperlipoproteinemia
SpecialtyDermatology

Medication-induced hyperlipoproteinemia is a condition that results from the decreasing of lipoprotein lipase activity resulting in eruptive xanthomas.[1]: 535 

See also

References

  1. ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.